- Record: found
- Abstract: not found
- Article: not found
Double-blind, randomized phase III study to compare the efficacy and safety of CT-P6, trastuzumab biosimilar candidate versus trastuzumab as neoadjuvant treatment in HER2 positive early breast cancer (EBC)
J STEBBING, Y V Baranau, V Baryash, A Manikhas, V Moiseyenko, G. Dzagnidze, Justin Stebbing, Yauheni Valerievich Baranau, Valery Baryash, Alexey Manikhas, Vladimir M. Moiseyenko, Giorgi Dzagnidze, Edvard Javrid, Dmytro Boliukh, Daniil Stroyakovskiy, Joanna Pikiel, Alexandru E. Eniu, Dmitry Komov, Zakaria Zautashvili, Gabriela Morar-Bolba, Rubi Li, Igor Lifirenko, Andriy V. Rusyn, Sang Joon LEE, Sung S. Lee, Francisco Esteva, J Stebbing, Y.V. Baranau, E Javrid, D. Boliukh, D Stroyakovskiy, J Pikiel
2017
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.